Insider Selling: Adtalem Global Education (NYSE:CVSA) CAO Sells 1,802 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) CAO Manjunath Gangadharan sold 1,802 shares of Adtalem Global Education stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $137.18, for a total value of $247,198.36. Following the transaction, the chief accounting officer owned 5,083 shares of the company’s stock, valued at approximately $697,285.94. This represents a 26.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

NYSE:CVSA traded down $5.97 during trading hours on Friday, reaching $134.71. The company had a trading volume of 388,853 shares, compared to its average volume of 368,459. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26. The stock has a 50 day moving average price of $127.08. The company has a market capitalization of $4.59 billion, a price-to-earnings ratio of 19.13, a PEG ratio of 1.02 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings data on Thursday, August 6th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The business had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. On average, analysts expect that Adtalem Global Education Inc. will post 9 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on CVSA shares. Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Truist Financial increased their price target on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Wednesday, August 19th. Finally, Barrington Research reissued an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $155.00.

Hedge Funds Weigh In On Adtalem Global Education

An institutional investor recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management bought a new stake in Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors and hedge funds.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.